EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PBP4 is required for serum-induced cell wall thickening and antibiotic tolerance in Staphylococcus aureus

Elizabeth V K Ledger iD, Ruth C Massey iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00961-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Elizabeth V K Ledger und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Microbiology, University College Cork, Cork, Ireland. Hauptthemen laut MEDLINE: Cell Wall, Penicillin-Binding Proteins, Anti-Bacterial Agents, Staphylococcus aureus. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIAID NIH HHS, Science Foundation Ireland (SFI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The bacterial pathogen Staphylococcus aureus responds to the host environment by synthesizing a thick peptidoglycan cell wall, which protects the bacterium from membrane-targeting antimicrobials and the immune response. However, the proteins required for this response were previously unknown. Here, we demonstrate by three independent approaches that the penicillin-binding protein PBP4 is crucial for serum-induced cell wall thickening. First, mutants lacking various non-essential cell wall synthesis enzymes were tested, revealing that a mutant lacking pbp4 was unable to generate a thick cell wall in serum. This resulted in reduced serum-induced tolerance of the pbp4 mutant toward the last resort antibiotic daptomycin relative to wild-type cells. Second, we found that serum-induced cell wall thickening occurred in each of a panel of 134 clinical bacteremia isolates, except for one strain with a naturally occurring mutation that results in an S140R substitution in the active site of PBP4. Finally, inhibition of PBP4 with cefoxitin prevented serum-induced cell wall thickening and the resulting antibiotic tolerance in the USA300 strain and clinical MRSA isolates. Together, this provides a rationale for combining daptomycin with cefoxitin, a PBP4 inhibitor, to potentially improve treatment outcomes for patients with invasive MRSA infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell WallPenicillin-Binding ProteinsAnti-Bacterial AgentsStaphylococcus aureusDaptomycinMicrobial Sensitivity TestsPeptidoglycanHumansStaphylococcal InfectionsCefoxitinBacterial ProteinsMethicillin-Resistant Staphylococcus aureusMutationSerum

Stichwörter der Autor:innen

PBP4Staphylococcus aureusantibiotic tolerancecell walldaptomycinpeptidoglycan

Substanzen

Penicillin-Binding ProteinsAnti-Bacterial AgentsDaptomycinPeptidoglycanCefoxitinBacterial Proteins

Autor:innen und Institutionen

  • School of Microbiology, University College Cork, Cork, Ireland.
  • APC Microbiome Ireland, University College Cork, Cork, Ireland.
  • Centre for Bacterial Resistance Biology, Imperial College London, London, United Kingdom.
  • School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.

ORCID-Profile: Elizabeth V K Ledger, Ruth C Massey

Förderung

  • Wellcome Trust
  • NIAID NIH HHS
  • Science Foundation Ireland (SFI)

Zitieren

APA

Ledger, E. V. K., & Massey, R. C. (2024). PBP4 is required for serum-induced cell wall thickening and antibiotic tolerance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00961-24

Vancouver

Ledger EVK, Massey RC. PBP4 is required for serum-induced cell wall thickening and antibiotic tolerance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00961-24

BibTeX
@article{Ledger2024,
  author = {Ledger, Elizabeth V K and Massey, Ruth C},
  title = {PBP4 is required for serum-induced cell wall thickening and antibiotic tolerance in Staphylococcus aureus},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00961-24}
}
Kostenlos starten →